Company intelligence / Profile preview

Arana Biosciences

Cambridge, MA, USApmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Preclinical

Overview

Arana Biosciences is developing a new platform technology that leverages advances in molecular and plant biology to create adaptive, targeted, and sustainable solutions for agriculture. The company is still early-stage with no disclosed clinical results as it does not operate in the therapeutic space.

Therapeutic areas: Other
Modalities: Platform technology in molecular and plant biologyRNA-based technologies
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Arana Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arana Biosciences.

Explore the full profile